Subjective and Pharmacodynamic Effects of the Novel 5-HT2A Receptor Agonist GM-2505 in Healthy Volunteers Show High Translatability From Rodent Data and Hold Promise for Future Development in Patients With Depression

被引：0

作者：

Hughes, Zoe ^{[1
]}

Christian, Edward ^{[1
]}

Dvorak, Dino ^{[1
]}

Umbricht, Daniel ^{[1
]}

Winters, Jason ^{[1
]}

Raines, Shane ^{[1
]}

Klein, Adam ^{[1
]}

Austin, Eric ^{[1
]}

Sporn, Jonathan ^{[1
]}

Kiss, Laszlo ^{[1
]}

Kruegel, Andrew ^{[1
]}

Makai-Boloni, Soma ^{[1
]}

Jacobs, Gabriel ^{[1
]}

Marek, Gerard ^{[1
]}

机构：

[1] Gilgamesh Pharmaceut, New York, NY USA

来源：

关键词：

Psychedelics; Major Depressive Disorder (MDD); Rapid-Acting Antidepressant; Translational Biomarker Approaches; to Drug Development;

D O I：

暂无

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

P238

引用

页码：202 / 203

页数：2